Gnrh Antagonist | List of Frontiers open access articles

Original Research

Published on 19 Jan 2023

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium

in Obstetrics and Gynecology

Depeng Zhao
Rui Xie
Xuemei Li

Frontiers in Medicine

doi 10.3389/fmed.2023.1071014

3,733 views
12 citations

Clinical Trial

Published on 13 Sep 2021

Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis

in Reproduction

Mingze Du
Junwei Zhang
Zhen Li
Xinmi Liu
Jing Li
Wenxia Liu
Yichun Guan

Frontiers in Endocrinology

doi 10.3389/fendo.2021.705264

6,600 views
42 citations

Original Research

Published on 27 May 2025

The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation: a retrospective study

in Obstetrics and Gynecology

Satoko Sasatsu
Yosuke Ono
Dai Miyashita
Tatsuya Yoshihara
Kota Tanaka
So Owada
Kana Makino
Akiko Nakagomi
Maki Ogi
Eriko Ogasawara

Frontiers in Medicine

doi 10.3389/fmed.2025.1543272

3,326 views
3 citations

Clinical Trial

Published on 22 Nov 2019

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial

in Reproduction

Qiuju Chen
Weiran Chai
Yun Wang
Renfei Cai
Shaozhen Zhang
Xuefeng Lu
Xiaojing Zeng
Lihua Sun
Yanping Kuang

Frontiers in Endocrinology

doi 10.3389/fendo.2019.00796

13,180 views
81 citations

Original Research

Published on 16 Jun 2023

Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score–matched cohort study

in Reproduction

Mingze Du
Junwei Zhang
Bingnan Ren
Yichun Guan

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1156620

3,794 views
14 citations

Original Research

Published on 13 Jul 2021

Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study

in Reproduction

Shan Liu
Minghui Liu
Lingxiu Li
Huanhuan Li
Danni Qu
Haiying Ren
Hui Su
Yang Zhang
Yuan Li

Frontiers in Endocrinology

doi 10.3389/fendo.2021.618580

5,172 views
3 citations

Original Research

Published on 18 Mar 2026

A drop in serum estradiol levels during GnRH antagonist cotreatment in cycles stimulated with gonadotropins is associated with lower cumulative live birth rates

in Reproduction

Lara Janssens
Ella Roelant
Christophe Blockeel
Diane De Neubourg

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1722379

572 views

Original Research

Published on 18 Nov 2021

Fixed Gonadotropin-Releasing Hormone Antagonist Protocol Versus Flexible Progestin-Primed Ovarian Stimulation Protocol in Patients With Asynchronous Follicular Development During Controlled Ovulation Stimulation: A Retrospective Study

in Reproduction

Mei Dong
Li Sun
Li Huang
Fang Wang
Xiqian Zhang
Fenghua Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2021.690575

7,440 views
14 citations

Original Research

Published on 07 Nov 2025

Impact of late follicular luteinizing hormone levels on live birth rate after fresh embryo transfer: a retrospective cohort study in GNRH antagonist cycles

in Reproduction

Nada Jelassi
Appoline Zimmermann
Cindy Faust
Laura Miquel
Christophe Buffat
Jeanne Perrin
Blandine Courbiere

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1615525

1,302 views

Original Research

Published on 19 May 2022

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle

in Cellular Endocrinology

Erkan Kalafat
Engin Turkgeldi
Sule Yıldız
Merve Dizdar
Ipek Keles
Baris Ata

Frontiers in Endocrinology

doi 10.3389/fendo.2022.837880

6,844 views
30 citations

Original Research

Published on 23 Jan 2026

Pregnancy outcomes of patients with retained products of conception following miscarriage treated with relugolix, an oral gonadotropin-releasing hormone antagonist

in Obstetrics and Gynecology

Satoko Sasatsu
Yosuke Ono
Dai Miyashita
Tatsuya Yoshihara
Kota Tanaka
Yuri Tada
So Owada
Akiko Nakagomi
Shoko Ikeda
Maki Ohgi

Frontiers in Medicine

doi 10.3389/fmed.2026.1704529

1,214 views

Original Research

Published on 12 Feb 2024

Effects of different gonadotropin preparations in GnRH antagonist protocol for patients with polycystic ovary syndrome during IVF/ICSI: a retrospective cohort study

in Reproduction

Zhengyan Hu
Rujun Zeng
Rui Gao
Mingli Chen
Xiumei Liu
Qiong Zhang
Lang Qin
Xun Zeng

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1309993

5,840 views
7 citations

Original Research

Published on 31 Oct 2023

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos

in Reproduction

Kazuhiro Takeuchi
Yuji Orita
Tokiko Iwakawa
Yukari Kuwatsuru
Yuko Kuroki
Yumiko Fukumoto
Yamato Mizobe
Mari Tokudome
Harue Moewaki

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1277873

4,634 views
1 citation

Original Research

Published on 14 Jun 2024

Effectiveness and safety of GnRH antagonist originator and generic in real-world clinical practice: a retrospective cohort study

in Reproduction

Mingzhu Cao
Yuqi Hu
Jiaqi Xiao
Sichen Li
Yanshan Lin
Jianqiao Liu
Haiying Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1358278

4,100 views
1 citation

Original Research

Published on 14 Sep 2021

A Novel Nomogram for Individualized Gonadotropin Starting Dose in GnRH Antagonist Protocol

in Reproduction

Yubin Li
Yuwei Duan
Xi Yuan
Bing Cai
Yanwen Xu
Yuan Yuan

Frontiers in Endocrinology

doi 10.3389/fendo.2021.688654

9,231 views
14 citations

Original Research

Published on 23 Dec 2024

LH level on trigger day, number of follicles ≥16 mm but <18 mm, and number of retrieved oocytes are independent risk factors for polyspermy in gonadotropin-releasing hormone antagonist protocol

in Reproduction

Qiongyu Wu
Lina He

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1521734

3,002 views

Articles

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium

Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis

The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation: a retrospective study

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial

Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score–matched cohort study

Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study

A drop in serum estradiol levels during GnRH antagonist cotreatment in cycles stimulated with gonadotropins is associated with lower cumulative live birth rates

Fixed Gonadotropin-Releasing Hormone Antagonist Protocol Versus Flexible Progestin-Primed Ovarian Stimulation Protocol in Patients With Asynchronous Follicular Development During Controlled Ovulation Stimulation: A Retrospective Study

Impact of late follicular luteinizing hormone levels on live birth rate after fresh embryo transfer: a retrospective cohort study in GNRH antagonist cycles

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle

Pregnancy outcomes of patients with retained products of conception following miscarriage treated with relugolix, an oral gonadotropin-releasing hormone antagonist

Effects of different gonadotropin preparations in GnRH antagonist protocol for patients with polycystic ovary syndrome during IVF/ICSI: a retrospective cohort study

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos

Effectiveness and safety of GnRH antagonist originator and generic in real-world clinical practice: a retrospective cohort study

A Novel Nomogram for Individualized Gonadotropin Starting Dose in GnRH Antagonist Protocol

LH level on trigger day, number of follicles ≥16 mm but <18 mm, and number of retrieved oocytes are independent risk factors for polyspermy in gonadotropin-releasing hormone antagonist protocol